ILLUMINA, INC. Accretion Expense
ILLUMINA, INC. (ILMN) reported Accretion Expense of $19.00 million for the 6-month period ending 2021-07-04, per its 10-Q filed 2021-08-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2021-08-06
- ILLUMINA, INC. accretion expense for the quarter ending 2015-06-28 was $729.00K, a 6.27% increase year-over-year.
- ILLUMINA, INC. accretion expense for the quarter ending 2015-03-29 was $607.00K, a 2.02% increase year-over-year.
- ILLUMINA, INC. accretion expense for the quarter ending 2014-12-28 was $690.00K, a 32.49% decline year-over-year.
- ILLUMINA, INC. accretion expense for the quarter ending 2014-09-28 was $666.00K, a 28.57% increase year-over-year.
- ILLUMINA, INC. accretion expense for fiscal 2014 was $2.64M, a 3.65% decline from fiscal 2013.
- ILLUMINA, INC. accretion expense for fiscal 2013 was $2.74M, a 28.60% increase from fiscal 2012.
- ILLUMINA, INC. accretion expense for fiscal 2012 was $2.13M.
| Period end | Accretion Expense 3 month | Accretion Expense 6 month | Accretion Expense 9 month | Accretion Expense 12 month |
|---|---|---|---|---|
| 2021-07-04 | $19.00M 10-Q · filed 2021-08-06 | |||
| 2020-06-28 | $19.00M 10-Q · filed 2021-08-06 | |||
| 2015-06-28 | $729.00K 10-Q · filed 2015-07-31 | $1.34M 10-Q · filed 2015-07-31 | $2.03M derived: sum of 3 quarters · filed 2015-07-31 | $2.69M derived: sum of 4 quarters · filed 2015-07-31 |
| 2015-03-29 | $607.00K 10-Q · filed 2015-05-01 | $1.30M derived: sum of 2 quarters · filed 2015-05-01 | $1.96M derived: sum of 3 quarters · filed 2015-05-01 | $2.65M derived: sum of 4 quarters · filed 2015-07-31 |
| 2014-12-28 | $690.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | $1.36M derived: sum of 2 quarters · filed 2015-02-18 | $2.04M derived: sum of 3 quarters · filed 2015-07-31 | $2.64M 10-K · filed 2015-02-18 |
| 2014-09-28 | $666.00K 10-Q · filed 2014-10-29 | $1.35M derived: sum of 2 quarters · filed 2015-07-31 | $1.95M 10-Q · filed 2014-10-29 | $2.97M derived: sum of 4 quarters · filed 2015-07-31 |
| 2014-06-29 | $686.00K 10-Q · filed 2015-07-31 | $1.28M 10-Q · filed 2015-07-31 | $2.30M derived: sum of 3 quarters · filed 2015-07-31 | $2.82M derived: sum of 4 quarters · filed 2015-07-31 |
| 2014-03-30 | $595.00K 10-Q · filed 2015-05-01 | $1.62M derived: sum of 2 quarters · filed 2015-05-01 | $2.13M derived: sum of 3 quarters · filed 2015-05-01 | $2.86M derived: sum of 4 quarters · filed 2015-05-01 |
| 2013-12-29 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | $1.54M derived: sum of 2 quarters · filed 2015-02-18 | $2.27M derived: sum of 3 quarters · filed 2015-02-18 | $2.74M 10-K · filed 2015-02-18 |
| 2013-09-29 | $518.00K 10-Q · filed 2014-10-29 | $1.25M derived: sum of 2 quarters · filed 2014-10-29 | $1.72M 10-Q · filed 2014-10-29 | $2.54M derived: sum of 4 quarters · filed 2015-02-18 |
| 2013-06-30 | $727.00K 10-Q · filed 2014-08-01 | $1.20M 10-Q · filed 2014-08-01 | $2.02M derived: sum of 3 quarters · filed 2015-02-18 | $4.08M derived: sum of 4 quarters · filed 2015-02-18 |
| 2013-03-31 | $471.00K 10-Q · filed 2014-05-07 | $1.29M derived: sum of 2 quarters · filed 2015-02-18 | $3.35M derived: sum of 3 quarters · filed 2015-02-18 | |
| 2012-12-30 | $823.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | $2.88M derived: sum of 2 quarters · filed 2015-02-18 | $2.13M 10-K · filed 2015-02-18 | |
| 2012-09-30 | $2.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-29 | $1.31M 10-Q · filed 2012-10-29 | ||
| 2012-07-01 | -$751.00K 10-Q · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WATERS CORP /DE/ (WAT) | United States | $42.297B | 224.28 |
| AGILENT TECHNOLOGIES, INC. (A) | United States | $48.720B | 27.14 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |